OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea · Delayed Price · Currency is KRW 10,560
-290 (-2.67%)
At close: Mar 6, 2026
OPTUS Pharmaceutical Market Cap
OPTUS Pharmaceutical has a market cap or net worth of 179.29 billion as of March 9, 2026. Its market cap has increased by 59.47% in one year.
Market Cap
179.29B
Enterprise Value
149.35B
Revenue
87.58B
Ranking
n/a
PE Ratio
13.90
Stock Price
10,560.00
Market Cap Chart
Since November 15, 2013, OPTUS Pharmaceutical's market cap has increased from 80.94B to 179.29B, an increase of 121.52%. That is a compound annual growth rate of 6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 186.35B | 53.49% |
| Dec 30, 2025 | 121.41B | 23.21% |
| Dec 30, 2024 | 98.53B | 14.66% |
| Dec 28, 2023 | 85.93B | -15.42% |
| Dec 29, 2022 | 101.60B | -9.40% |
| Dec 30, 2021 | 112.14B | -19.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 250.31B |
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |
| Organoidsciences | 187.36B |
| GREEN CROSS WellBeing | 168.05B |
| High Tech Pharm | 166.94B |
| Kyung Dong Pharmaceutical | 148.18B |
| DongKoo Bio & Pharma | 145.49B |